The TLR4/NF-κB pathway (β = 0.570) directly promoted liver fibrosis, whereas the Nrf2/Keap1 pathway (β = −0.486) inhibited it (P < 0.01). Here, NFE2L2 is linked to Hepatic fibrosis.